The Intranasal Antidepressant market was valued at USD 780.00 Million in 2024 and is expected to reach USD 1,328.20 Million by 2032, growing at a CAGR of 6.88% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.